±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 454  |  »Ø¸´: 1

hnzmm

Í­³æ (³õÈëÎÄ̳)

[ÇóÖú] Çó·­Òë

ÊÔÑé½á¹ûÏÔʾ£¬×¡ÔºÆÚ¼ä£¬ÊÔÑé×黼ÕßµÄÓÃÒ©ÒÀ´ÓÐԺͿ¹¾úÒ©Îï¹æ·¶ºÏÀíʹÓÃˮƽÏÔÖø¸ßÓÚ¶ÔÕÕ×飬ҩÎï²»Á¼Ê¼þµÄ·¢ÉúÂÊÏÔÖøµÍÓÚ¶ÔÕÕ×飬¶ÔÓÚ´«Í³Ò½Áƹý³ÌºÍÓÃÒ©¼à»¤¹ý³ÌµÄÂúÒâ¶ÈÏÔÖø¸ßÓÚ¶ÔÕÕ×飬Á½×éÏà±È¾ù¾ßÓÐÏÔÖøÐÔ²îÒ죨P£¼0.05£©£»³öÔººóÁ½×黼ÕßµÄÓÃÒ©ÒÀ´ÓÐÔ¡¢¸´Õï»òÔÙÈëÔºÂʼ°ÓÃÒ©Æ«²îÎÞÏÔÖøÐÔ²îÒ죨P£¾0.05£©£¬¶ø¶ÔÓÚÒ©Îï²»Á¼Ê¼þµÄÈÏÖª¶ÈºÍҩѧָµ¼µÄÂúÒâÂÊÊÔÑé×éÈÔ¸ßÓÚ¶ÔÕÕ×飬Á½×éÏà±È¾ßÓÐÏÔÖøÐÔ²îÒ죨P£¼0.05£©¡£
       ±¾Ñо¿Ê״ν¨Á¢ÁËCOPDҩѧ·¾¶ºÍËæ·Ã¼Æ»®£¬ÔÚÁÙ´²¹¤×÷ÖÐÊܵ½ÁËÒ½»¤ÈËÔ±ºÍ»¼ÕßµÄºÃÆÀ¡£ÕâÊÇҩѧ·þÎñ·¾¶¹¤×÷ģʽÔÚCOPDµÄ³É¹¦Ó¦Óã¬Ò²Îª¸Ã¹¤×÷ģʽÔÚÆäËûÂýÐÔ¼²²¡µÄÍÆ¹ã»ýÀÛÁ˷ḻµÄ¾­Ñé¡£
        ¶ÔÓÚ½ÓÊܶàÒ©ÖÎÁƵÄCOPDסԺ»¼Õߣ¬×ñѭҩѧ·þÎñ·¾¶½øÐÐÈ«³Ì»¯¡¢¹æ·¶»¯¡¢Í¬ÖÊ»¯µÄҩѧ¼à»¤£¬¿ÉÃ÷ÏÔÌá¸ßסԺ»¼ÕßµÄÓÃÒ©ÒÀ´ÓÐÔ¡¢ÂúÒâ¶ÈºÍ¿¹¾úÒ©Îï¹æ·¶ºÏÀíʹÓÃˮƽ£¬ÏÔÖø½µµÍÒ©Îï²»Á¼Ê¼þµÄ·¢ÉúÂÊ£¬µ«ÊǶÔÓÚ³öÔººó¸´Õï»òÔÙÈëÔºÂʼ°ÓÃÒ©Æ«²îÎÞÏÔÖøÓ°Ïì¡£±¾ÊÔÑé½á¹ûÖ¤Ã÷£¬×ñÑ­¹æ·¶»¯µÄҩѧ·þÎñ¹¤×÷ģʽ¿ÉÒÔ±£Ö¤»¼ÕßÓÃÒ©µÄ°²È«ÐÔ£¬Ìá¸ßÁÙ´²¿¹¾úÒ©Îï¹æ·¶ºÏÀíʹÓÃˮƽ£¬±£Ö¤Ò½ÁÆÖÊÁ¿£¬Ìá¸ß»¼ÕßµÄÂúÒâ¶È¡£ÁÙ´²Ò©Ê¦ÒÔ´ËΪÇÐÈëµã¿ªÕ¹¹æ·¶»¯µÄҩѧ·þÎñ¹¤×÷£¬¶ÔÓÚÌá¸ßÂýÐÔ²¡»¼ÕßÖÎÁÆË®Æ½ºÍÉú»îÖÊÁ¿¾ßÓÐÖØÒªµÄÒâÒ塣ͬʱ£¬ÁÙ´²Ò©Ê¦Ó¦ÉîÈëÉçÇø»ý¼«¿ªÕ¹ÉçÇøÒ©Ñ§·þÎñ¹¤×÷£¬Ìá¸ßÀÏÄêÂýÐÔ¼²²¡»¼ÕßµÄÓÃÒ©ÒÀ´ÓÐÔ£¬¼õÉÙÓÃÒ©Æ«²î£¬¸ÄÉÆ»¼ÕßÉú»îÖÊÁ¿¡£

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

1490690342

½ð³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
RXMCDM: ½ð±Ò-10, ÇëÏÈ¿´¿´Ó¦Öú±Ø¶Á£¬»úÆ÷·­ÒëÏ´ÎÖØ·££¡ 2014-09-29 23:59:06
Test results show that, during the period of hospitalization, the test group patients compliance and the rational use of antibiotics was significantly higher than the control group, the incidence rate of adverse drug events was significantly lower than the control group, the traditional medical process and drug monitoring process satisfaction was significantly higher than that in control group, compared to the two groups were significant difference (P < 0.05 after discharge from hospital); the two groups of patients with medication compliance, referral or readmission rate and medication deviation of no significant difference (P > 0.05), and for recognition and Pharmacy Guide adverse drug events of the satisfaction rate of the experimental group was higher than that of control groups, compared to the two groups have significant difference (P < 0.05).

This study established the first COPD pharmacy path and follow-up plan, in the clinical work by the medical staff and patients of praise. This is the pharmacy service path modes in the successful application of COPD, but also for the work mode in the promotion of other chronic diseases has accumulated rich experience.

For multi drug therapy in hospitalized COPD patients, pharmaceutical care to follow the path of the whole process of pharmacy services, standardization, homogenization, can significantly improve the hospitalized patients with medication compliance, satisfaction and the rational use of antibiotics, significantly reduce adverse drug event rate, but for a referral or readmission after discharge the rate of deviation and medication had no significant effect. The test results show that, the pharmaceutical service mode to follow standardized can ensure patient safety, improve the clinical rational use of antibacterial drug level, ensure the quality of medical care, improve patient satisfaction. Clinical pharmacists as pharmaceutical services starting point to carry out standardization, has important significance for improving the treatment of patients with chronic diseases and the level of quality of life. At the same time, clinical pharmacists should further community actively participate in community pharmacy services, improve the medication compliance of senile patients with chronic disease, reduce medication error, improve the life quality of patients.
2Â¥2014-09-29 14:27:39
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ hnzmm µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 272·ÖÇóµ÷¼Á +4 wangyile2233 2026-04-02 4/200 2026-04-05 22:21 by 286640313
[¿¼ÑÐ] Ò»Ö¾Ô¸ºÓ±±¹¤Òµ´óѧ²ÄÁϹ¤³Ì£¬³õÊÔ344Çóר˶µ÷¼Á +3 15933906766 2026-04-05 3/150 2026-04-05 22:17 by dongzh2009
[¿¼ÑÐ] 262Çóµ÷¼Á +7 ÌìϵÚÒ»ÎÄ 2026-04-04 8/400 2026-04-05 21:31 by ¼¤Á÷Ó¶É
[˶²©¼ÒÔ°] 0856²ÄÁÏ»¯¹¤Çóµ÷¼Á£¬Ò»Ö¾Ô¸211£¬³õÊԳɼ¨349 +3 ½­»´±±Ô 2026-04-05 3/150 2026-04-05 20:31 by à£à£à£0119
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +13 Ò»ÑùYWY 2026-04-03 14/700 2026-04-05 18:20 by À¶ÔÆË¼Óê
[¿¼ÑÐ] µ÷¼ÁÇóÖú +10 Ïë»»ÊÖ»ú²»Ïë½âÊ 2026-04-02 13/650 2026-04-05 09:41 by sam3303
[¿¼ÑÐ] 309Çóµ÷¼Á +6 ÁõÁõÁõ1231 2026-04-02 7/350 2026-04-04 13:41 by liucky
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³Ì339Çóµ÷¼Á +12 hyz0119 2026-03-31 13/650 2026-04-03 18:33 by lsÁõ˧
[¿¼ÑÐ] ¿¼Ñе÷¼Á +8 ²»°®ºÈÒûÁÏ 2026-04-03 8/400 2026-04-03 16:40 by Mistake-J
[¿¼ÑÐ] 338Çóµ÷¼Á +4 zzz£¬£¬r 2026-04-03 4/200 2026-04-03 16:39 by lijunpoly
[¿¼ÑÐ] Çóµ÷¼Á +4 15064154688 2026-04-03 5/250 2026-04-03 15:07 by zrongyan
[¿¼ÑÐ] ÍÁľˮÀû328·ÖÇóµ÷¼Á +6 ¼²·çÖª¾¢²Ý666 2026-04-02 6/300 2026-04-03 11:38 by znian
[¿¼ÑÐ] ²ÄÁÏ¿¼Ñе÷¼Á +10 Gs´óÍõ 2026-04-02 10/500 2026-04-03 09:47 by ÒÅÍüÏûʧµÄž™
[¿¼²©] É격ÇóÖú +3 Reee1Llll 2026-04-01 3/150 2026-04-02 22:29 by ÕâÊÇÒ»¸öÎÞÁĵÄê
[¿¼ÑÐ] Çóµ÷¼ÁÍÆ¼ö +3 ÄÏɽÄÏ@ 2026-04-01 3/150 2026-04-02 12:09 by xiaoranmu
[¿¼ÑÐ] 270µ÷¼Á +7 maxjxbsk 2026-04-02 7/350 2026-04-02 09:50 by yulian1987
[¿¼ÑÐ] 298Çóµ÷¼Á +4 ʲôÊÇÅÖÍ·Óã 2026-03-30 6/300 2026-04-01 22:06 by ¿Í¶ûÃÀµÂ
[¿¼ÑÐ] 070300»¯Ñ§279Çóµ÷¼Á +15 ¹þ¹þ¹þ^_^ 2026-03-31 17/850 2026-04-01 21:37 by ¸øÄãÄã×¢ÒâÐÝÏ¢
[¿¼ÑÐ] 339Çóµ÷¼Á +5 zjjkt 2026-03-31 5/250 2026-04-01 09:18 by JourneyLucky
[¿¼ÑÐ] ÍÁľ304Çóµ÷¼Á +5 ¶¥¼¶²Á²Á 2026-03-31 5/250 2026-04-01 08:15 by fdcxdystjk£¤
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û